HistoWiz is a biotechnology company that automates histopathology for biomedical researchers. Our rapid online services and intelligent tissue platform enable discovery and advancements in the field by allowing tissue-driven data mining for the first time.

Since inception in 2013, HistoWiz has over 1,000 customers globally from top academic institutions (e.g. MSKCC, Harvard, Stanford, HHMI) and pharmaceutical companies (e.g. CRISPR, Johnson & Johnson, Regeneron). We are profitable, won numerous awards and are funded by prestigious investors, including Y Combinator and Zhenfund. We are seasoned scientists with experience at leading academic institutions and have published high impact research in top journals of biomedicine.